| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/08/2009 | CN201216753Y Dressings emplastrum for relieving pain of tumour |
| 04/08/2009 | CN101405285A Cyclic-alkylaminederivatives as inhibitors of the interaction between MDM2 and P53 |
| 04/08/2009 | CN101405281A Inhibitors of the interaction between MDM2 and P53 |
| 04/08/2009 | CN101405029A Treatment of metastatic breast cancer |
| 04/08/2009 | CN101405025A Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
| 04/08/2009 | CN101405014A Water having anticancer action and method for producing the same |
| 04/08/2009 | CN101405002A Prokineticin 2 receptor antagonists |
| 04/08/2009 | CN101404996A Composition containing lignan compound |
| 04/08/2009 | CN101404988A Breast cancer treatment regimen |
| 04/08/2009 | CN101402982A Mud snail glue polysaccharide, preparation method and application thereof |
| 04/08/2009 | CN101402956A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402942A PolyLyse-HSP70 fusion protein film modified intestinal cancer cytoma vaccine and method of producing the same |
| 04/08/2009 | CN101402736A Biodegradable unsaturated polyphosphate, preparation and use method thereof |
| 04/08/2009 | CN101402686A Antihuman Endoglin single-chain antibody, preparation and uses thereof |
| 04/08/2009 | CN101402685A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402675A Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides |
| 04/08/2009 | CN101402668A Novel antineoplastic compound of holothuria nobilis selenka saponin C in holothuria nobilis selenka |
| 04/08/2009 | CN101402667A Glycosylation modified nitric oxide donor type oleaolic acid compounds, preparation and uses thereof |
| 04/08/2009 | CN101402666A Saponin with immunoadjuvant function, preparation method, vaccine preparation containing the saponin as adjuvant and uses thereof |
| 04/08/2009 | CN101402662A Process for producing nelarabine |
| 04/08/2009 | CN101402655A Process for producing platinum |
| 04/08/2009 | CN101402650A Organotin coordination compound, preparation and uses thereof |
| 04/08/2009 | CN101402640A Diester camptothecin derivative, preparation method and uses thereof |
| 04/08/2009 | CN101402639A 20(S)-7-(2-furoyl) camptothecinum and synthesis thereof |
| 04/08/2009 | CN101402638A 20(S)-7-pentanoyl camptothecinum and synthesis thereof |
| 04/08/2009 | CN101402632A Aryl hydrazide compounds with antineoplastic activity |
| 04/08/2009 | CN101402631A Amino quinazoline 2-maleate, production method and uses thereof |
| 04/08/2009 | CN101402621A Aryl furfuran formyl hydrazone compounds with antineoplastic activity |
| 04/08/2009 | CN101402620A Benzoyl hydrazone compounds with antineoplastic activity |
| 04/08/2009 | CN101402619A Novel 2-deoxidizedfructofuranose derivative, preparation method and medical uses thereof |
| 04/08/2009 | CN101402611A Compound with anti-leukocythemia liveness and method of preparing the same |
| 04/08/2009 | CN101402587A Substituted acethydrazide derivatives, preparation method and application thereof |
| 04/08/2009 | CN101402573A Bihydroxyl-2-acyl benzene acetic acid ester, producing method and uses thereof |
| 04/08/2009 | CN101402555A Method of preparing (Z)-3'-hydroxyl-3,4,4',5-tetramethoxy toluylene |
| 04/08/2009 | CN101402544A Industrial production method of high-purity beta-elemi alkene bulk medicament |
| 04/08/2009 | CN101402543A Beta-elemi alkene bulk medicament and method of preparing its preparations |
| 04/08/2009 | CN101401944A Method of preparing iodine-125 sealing seed source core |
| 04/08/2009 | CN101401941A Preparation and uses of tumor-targeted carrier material RGD-fatty alcohol series of compounds |
| 04/08/2009 | CN101401938A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101401915A Chinese medicine formulation for treating cancer and preparation method thereof |
| 04/08/2009 | CN101401907A Particle for increasing body resistance and consolidating constitution |
| 04/08/2009 | CN101401905A Chinese medicinal composition for treating aplastic anemia |
| 04/08/2009 | CN101401896A Active principle of sarsaparilla and extracting method thereof |
| 04/08/2009 | CN101401891A Traditional Chinese medicine decoction for treating aplastic anemia |
| 04/08/2009 | CN101401832A Uses of dysosma versipellis extract in preparing anti-tumor medicament |
| 04/08/2009 | CN101401828A Technique for processing yew decoction tablet |
| 04/08/2009 | CN101401823A Enterococcus faecalis cell wall polysaccharide body substance and uses thereof |
| 04/08/2009 | CN101401808A Application of scopoletin in preparing medicament for treating or preventing tumour |
| 04/08/2009 | CN101401806A Uses of sugar apple lactone monomeric compound in preparing medicament for treating lung cancer, mammary cancer or liver cancer |
| 04/08/2009 | CN101401803A Uses of 2,5-dewatering-D-glucitol and the like in preparing cancer treatment medicament |
| 04/08/2009 | CN101401801A Curcumin glutin microsphere and preparation thereof |
| 04/08/2009 | CN101401797A Effervescent tablet containing imatinib mesylate and preparation method thereof |
| 04/08/2009 | CN101401795A Imatinib mesylate orally disintegrating tablets and preparation method thereof |
| 04/08/2009 | CN101401794A Imatinib mesylate chewable tablet and preparation method thereof |
| 04/08/2009 | CN101401792A Method for preparing nanocapsule and nanocapsule composite microsphere |
| 04/08/2009 | CN101401789A Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 04/08/2009 | CN101401786A Nelarabine injection |
| 04/08/2009 | CN100475966C New-type adenovirus with tumor cell specific infection and transgenic expression capability |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475840C Wasp antibiotic peptide and preparing method and use thereof |
| 04/08/2009 | CN100475835C 23-Hydroxyl betulinic acid kind derivant and preparing process, preparation and use thereof |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475814C 7-azaindoles and use thereof as therapeutic agents |
| 04/08/2009 | CN100475812C Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 04/08/2009 | CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 04/08/2009 | CN100475753C Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion |
| 04/08/2009 | CN100475707C Method for preparing magnetic Nano composite granules coated by cationic polyelectrolyte |
| 04/08/2009 | CN100475271C Somatostatin analogs with inhibitory activity to growth hormone release |
| 04/08/2009 | CN100475270C Medicine for treating tumor, and application thereof |
| 04/08/2009 | CN100475243C Hypoglycemic, antilipenic and hemopathy-treating glutinous rehmannia extract and preparing method thereof |
| 04/08/2009 | CN100475227C Antitumor medicine composition and preparing method thereof |
| 04/08/2009 | CN100475212C Combination of a nitrogen mustard analogue and imatinib mesylate for the treatment of chronic lymphocytic leukemia |
| 04/08/2009 | CN100475207C 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 04/08/2009 | CN100475203C Preparing method of triptolide molecule microcapsule |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | US7514469 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514447 e.g. [2-(4-Isopropyl-piperazin-1-yl)-benzooxazol-6-yl]-[5-(4-methoxy-phenyl)-pyrimidin-2-yl]-amine; C-kit kinase receptor or stem cell factor inhibitors; anticarcinogenic agents; veterinary medicine |
| 04/07/2009 | US7514446 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 04/07/2009 | US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors) |
| 04/07/2009 | US7514442 Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/07/2009 | US7514435 Pyrrolotriazine kinase inhibitors |
| 04/07/2009 | US7514432 5-[5-(Benzo[b]thiophen-7-yloxy)-pentyloxy]-2-(tetrahydro-pyran-2-yloxymethyl)-4H-pyran-4-one; antiproliferative and antiangiogenic activities; to treat cancers (such as leukemia), ocular diseases and arthritis; excellent bioavailability and pharmacokinetic properties |
| 04/07/2009 | US7514418 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514231 Anti-aurora-A monoclonal antibody, method for obtaining same and uses thereof for diagnosing and treating cancers |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514221 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/07/2009 | US7514105 Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | US7514095 Three-dimensional chitosan matrix or drug release; tissue engineering ; water in oil emulsion containing active materials; extrusion; coagulation |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514084 isolated nonapeptide that bind to an human leukocyte antigen (HLA-A 0201) restricted T cell receptors with high affinity and induce a high cytotoxic T lymphocyte response, used for treating or preventing tumors and cancers |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2493633C Kinase inhibitors |